Contribution of angiotensin receptor type II to dermal extravasation caused by bradykinin in mice: Implications for sartan-induced angioedema
Authors:
- Vu Thao-Vi DaoVDVu Thao-Vi Dao
- Ehsan FahimiEFEhsan Fahimi
- Marion BishaMBMarion Bisha
- Thomas KurzTKThomas Kurz
- Finn Kristian HansenFHFinn Kristian Hansen
- Cansu AközbekCACansu Aközbek
- Tatsiana SuvoravaTSTatsiana Suvorava
- Georg KojdaGKGeorg Kojda
Open Access
- 12 November 2026
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 205
Abstract
No abstract availableFunding Information
- Deutsche Forschungsgemeinschaft
This publication has 59 references indexed in Scilit:
- Functional assay for assessment of agonistic or antagonistic activity of angiotensin AT2 receptor ligands reveals that EMA401 and PD123319 have agonistic propertiesBiochemical Pharmacology, 2023
- Contribution of cyclooxygenase-1-dependent prostacyclin synthesis to bradykinin-induced dermal extravasationBiomedicine & Pharmacotherapy, 2022
- Cyclooxygenase activity in bradykinin-induced dermal extravasation. A study in mice and humansBiomedicine & Pharmacotherapy, 2020
- Isolated intestinal type angioedema due to ACE ‐inhibitor therapyClinical Case Reports, 2017
- Nitric oxide up-regulates endothelial expression of angiotensin II type 2 receptorsBiochemical Pharmacology, 2016
- Treatment of angiotensin receptor blocker-induced Angioedema: A case seriesThe Laryngoscope, 2015
- Impact of the AT2 Receptor Agonist C21 on Blood Pressure and BeyondCurrent Hypertension Reports, 2012
- Long-term effects of telmisartan on blood pressure, the renin-angiotensin-aldosterone system, and lipids in hypertensive patientsHeart and Vessels, 2010
- Vascular permeability, vascular hyperpermeability and angiogenesisAngiogenesis, 2008
- Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type 1 receptor antagonistsAmerican Journal of Hypertension, 2005